Clinical Trials Sponsored by Hebei Yiling Hospital

Total 1748 results

Hebei Yiling Hospital
London South Bank University

Completed

Bromelain and Cardiovascular Risk Factors in Diabetes (BRCARDIO)

Cardiovascular Disease.

China
Hebei Tumor Hospital

Unknown

Pilot Study of Zoledronic Acid in Combination With First-line Chemotherapy in Aged Patients With Lung Cancer

Lung Cancer

China
Hebei Tumor Hospital

Unknown

A Study of Raltitrexed Plus Docetaxel Versus Docetaxel as Second-line Chemotherapy in Subjects With Gastric Cancer

Gastric Cancer

China
Hebei Tumor Hospital

Unknown

Study Comparing Sequential Therapy of S1+Docetaxel Followed by S1 to Concomitant S1+Docetaxel for Advanced Gastric Cancer

Gastric Cancer

China
Hebei General Hospital

Unknown

Cognitive Impairment , Neuroimaging and Inflammatory Markers in Patients With Subcortical Ischemic Vascular Disease

Other Generalized Ischemic Cerebrovascular Disease

China
Hebei General Hospital

Completed

Effect of Acupuncture Combined With Biofeedback Electrical Stimulation on SUI

Stress Urinary Incontinence

China
Hebei Tumor Hospital

Unknown

Safety and Efficacy of Ginsenoside Rg3 in Combination With First-line Chemotherapy in Advanced Gastric Cancer

Self Efficacy

China
Hebei Province Veterans Hospital

Completed

Dance/Movement Therapy for Bone Mineral Density in Schizophrenia

Schizophrenia

China
Hebei Yanda Ludaopei Hospital

Completed

LILRB4 STAR-T Cells in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia

Relapsed/Refractory Acute Myeloid Leukemia

China
Ahon Pharmaceutical Co., Ltd.
Affiliated Hospital of Hebei University; The First Hospital of Jilin University and other collaborators

Recruiting

Study of Efficacy, Safety, and Pharmacokinetics of FCN-437c in Combination With Fulvestrant or Letrozole+Goserelin

Breast Neoplasms

China
Hebei Senlang Biotechnology Inc., Ltd.
Hebei Yanda Ludaopei Hospital

Recruiting

Safety and Efficacy of CD19/CD22 Dual Targeted CAR-T Cell Therapy in R/R B-Cell Acute Lymphoblastic Leukemia

CD19+ and CD 22+ B-ALL

China
Hebei Senlang Biotechnology Inc., Ltd.
Hebei Yanda Ludaopei Hospital

Active, not recruiting

Senl_1904A and Senl_1904B Chimeric Antigen Receptor （CAR） T-Cell in the Treatment of r/ r Acute B Lymphocytic Leukemia

Acute Lymphocytic Leukemia

China
Hebei Yanda Ludaopei Hospital

Not yet recruiting

Study on Intelligent Nutrition Support Therapy for Hematopoietic Stem Cell Transplantation Recipients

Nutrition Aspect of Cancer | Stem Cell Transplant Complications
Hebei Yanda Ludaopei Hospital

Unknown

A Study of BCMA-directed CAR-T Cells Treatment in Subjects With r/r Multiple Myeloma

Relapsed or Refractory Multiple Myeloma

China
Hebei Senlang Biotechnology Inc., Ltd.
Hebei Yanda Ludaopei Hospital

Unknown

Study Evaluating Safety and Efficacy of CAR-T Cells Targeting CD123 in Patients With Acute Myelocytic Leukemia

Acute Myelocytic Leukemia

China
Hebei Senlang Biotechnology Inc., Ltd.
Hebei Medical University Fourth Hospital

Recruiting

Clinical Trial of CAR-T in the Treatment of Relapsed and Refractory Hematopoietic and Lymphoid Tissue Tumors in Children

Lymphoma | Leukemia

China
Wuling Ou
Jiangsu HengRui Medicine Co., Ltd.; Hubei Clinical Research Collaboration Group

Unknown

Apatinib Mesylate Combined With Pemetrexed in the Treatment of Pretreated Advanced Non-squamous Non-small Cell Lung Cancer

Nonsmall Cell Lung Cancer

China
Hebei Senlang Biotechnology Inc., Ltd.
Hebei Medical University Fourth Hospital

Recruiting

Multicenter Clinical Study on the Safety and Effectiveness of CAR-T in the Treatment of Relapsed/Refractory Plasma Cell Tumors

Plasma Cell Tumors

China
Hebei Medical University Fourth Hospital

Recruiting

Durvalumab Combined With Chemoradiotherapy for Limited Stage Small Cell Lung Cancer (Camel-01)

SCLC, Limited Stage

China
Hebei Medical University Fourth Hospital

Recruiting

The Efficacy and Safety of Pyrotinib, Trastuzumab Combined With Taxanes in the Treatment of Trastuzumab-treated HER2+ Advanced Breast Cancer (ABC).

Advanced Breast Cancer | HER2-positive Breast Cancer

China
Hebei Medical University Fourth Hospital

Recruiting

Dalpiciclib Plus AI (Neoadjuvant Endocrine Therapy) Compared With Neoadjuvant Chemotherapy in Early Breast Cancer （EBC）

Breast Cancer

China
Hebei Medical University Fourth Hospital

Recruiting

Efficacy and Safety of Tislelizumab for Lung Adenocarcinoma With Asymptomatic Brain Metastatic

Lung Adenocarcinoma

China
Hebei Medical University Fourth Hospital

Not yet recruiting

Olaparib in the Treatment of BRCA1/2 Unmutated and BRCA1 Promoter Methylated Recurrent and Metastatic Triple-negative Breast Cancer

Solid Tumor
Hebei Medical University Fourth Hospital

Recruiting

Short-course Radiotherapy Followed by Tislelizumab + CapeOX in the Treatment for Locally Advanced Rectal Cancer

Locally Advanced Rectal Cancer

China
Hebei Medical University Fourth Hospital

Recruiting

A Study of Camrelizumab As Consolidation Therapy After Radical Concurrent Chemoradiotherapy In Locally Advanced ESCC (ESCC)

Esophageal Cancer

China
Hebei Medical University Fourth Hospital

Recruiting

Study of Anti-PD-1 Antibody Multimodal Combination as First-line Treatment on Time Window of Advanced Solid Tumor

Advanced Solid Tumor

China
Hebei Medical University Fourth Hospital

Recruiting

Neoadjuvant Therapy With Nab-paclitaxel and Cisplatin for Locally Advanced Esophageal Squamous Cell Carcinoma (NTNC)

Esophageal Squamous Cell Carcinoma

China
Hebei Medical University Fourth Hospital

Not yet recruiting

Clinical Research on the Effect of Aspirin on the Disease Free Survival Rate of Esophageal Carcinoma

Aspirin as an Adjuvant Therapy, to Observe Its Effect on the Disease Free Survival Rate of Patients With Esophageal Squamous Cell Carcinoma

China
Hebei Medical University Fourth Hospital

Not yet recruiting

A Prospective Study of Apatinib Plus Concurrent Neoadjuvant Chemoradiotherapy in Patients With Esophageal Squamous Cell Carcinoma

Esophageal Squamous Cell Carcinoma
Hebei Medical University Third Hospital

Withdrawn

Characteristic Analysis and Surgical Exploration for Acetabular Roof Fractures: Multicenter Retrospective Cohort Study (CASEARF)

Acetabular Fracture

China
Hebei Medical University Third Hospital

Completed

The Efficacy of PRP Combined With Exercise to Treat Knee Osteoarthritisq

Knee Osteoarthritis | Physical Exercise | Platelet-rich Plasma

China
Hebei Medical University Fourth Hospital

Unknown

A Study of Apatinib Plus EGFR-TKI as First Line Treatment in Patients With Non-squamous NSCLC Harboring EGFR Mutations

NSCLC

China
Hebei Medical University Fourth Hospital

Unknown

Prospective, Multicenter, Observational Study of Apatinib Single or Combined Capecitabine for Treatment of Patients With Metastatic Her-2 Negative Breast Cancer

Breast Cancer Metastatic

China
Hebei Medical University Third Hospital

Unknown

Pelvic and Acetabular Fracture in Old People

Fracture Dislocation

China
Hebei Medical University Third Hospital

Completed

Prediction of the Collapse of Necrotic Femoral Head Using Computed Tomography Scan and X-ray Before Hip Arthroplasty

Hip Arthropathy
Hebei Medical University Third Hospital

Unknown

Posterior Wall Osteotomy for Old Acetabular Fracture (osteotomy)

Surgical Procedure, Unspecified

China
Hebei Medical University Third Hospital

Unknown

Study of PLGA-Mg Material in Clinical Orthopedics

Fracture Dislocation

China
Hebei Yanda Hospital
Beijing Tiantan Hospital

Unknown

Safety and Efficacy of IDH1R132H-DC Vaccine in Gliomas

Glioma

China
Hebei Yanda Hospital
Beijing Tiantan Hospital

Unknown

Ultra-low Dose Bevacizumab Plus Temozolomide for Recurrent High-grade Gliomas

Recurrent High-grade Glioma

China
Han Ying

Recruiting

Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cholangitis

Primary Biliary Cholangitis

China
Hebei Medical University Third Hospital

Recruiting

Evaluation of AKR1B10 as a New Marker for Interventional Therapy of Hepatocellular Carcinoma

Hepatocellular Carcinoma

China
Hebei Medical University Fourth Hospital

Not yet recruiting

Liposomal Irinotecan and Leucovorin/5-fluorouracil Plus Bevacizumab in Metastatic Colorectal Cancer

Colorectal Cancer
Hebei Medical University Third Hospital

Recruiting

Mechanism of Cardiac and Cerebral Function Injury Caused by Intraoperative Limb Ischemia-reperfusion

Ischemic Reperfusion Injury

China
Hebei Medical University Fourth Hospital

Not yet recruiting

Efficacy and Safety of Dalpiciclib in Hormone Receptor-positive Advanced Breast Cancer

Breast Cancer
Hebei Medical University Fourth Hospital

Not yet recruiting

Dalpiciclib Combined With Letrozole in Neoadjuvant Treatment of Stage Ⅱ-Ⅲ HR-positive/HER2-negative Breast Cancer

Solid Tumor
Hebei Medical University Fourth Hospital

Recruiting

Adjuvant Therapy of Ensartinib in Stage IB-IIIA ALK-positive Non-small Cell Lung Cancer

Non-small Cell Lung Cancer

China
Hebei Medical University Third Hospital

Recruiting

The Research About the ACS After Femoropopliteal Arterial Injuries

Acute Compartment Syndrome

China
Hebei Medical University Third Hospital

Recruiting

The Research About Acute Compartment Syndrome

Acute Compartment Syndrome

China
Hebei Medical University Fourth Hospital

Not yet recruiting

Neoadjuvant Chemotherapy With Pyrotinib, Epirubicin and Cyclophosphamide Followed by Taxanes and Trastuzumab for HER-2+ Breast Cancer

Breast Cancer
Hebei Medical University Third Hospital

Completed

Anti-fibrinolytic and Anti-inflammatory Effects of Local Infiltration of Tranexamic Acid in Patients With Calcaneal Fractures

Fibrinolysis | Fracture | Tranexamic Acid | Inflammatory

China

3

Subscribe